These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31597224)

  • 1. Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infants.
    Moreno-Galdó A; Pérez-Yarza EG; Ramilo O; Rubí T; Escribano A; Torres A; Sardón O; Oliva C; Pérez G; Cortell I; Rovira-Amigo S; Pastor-Vivero MD; Pérez-Frías J; Velasco V; Torres J; Figuerola J; Barrio MI; García-Hernández G; Mejías A;
    Pediatr Allergy Immunol; 2020 Feb; 31(2):124-132. PubMed ID: 31597224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.
    Mochizuki H; Kusuda S; Okada K; Yoshihara S; Furuya H; Simões EAF;
    Am J Respir Crit Care Med; 2017 Jul; 196(1):29-38. PubMed ID: 28152315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life.
    Pérez-Yarza EG; Moreno-Galdó A; Ramilo O; Rubí T; Escribano A; Torres A; Sardón O; Oliva C; Pérez G; Cortell I; Rovira-Amigo S; Pastor-Vivero MD; Pérez-Frías J; Velasco V; Torres-Borrego J; Figuerola J; Barrio MI; García-Hernández G; Mejías A;
    Pediatr Allergy Immunol; 2015 Dec; 26(8):797-804. PubMed ID: 26031206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants.
    Yoshihara S; Kusuda S; Mochizuki H; Okada K; Nishima S; Simões EA;
    Pediatrics; 2013 Nov; 132(5):811-8. PubMed ID: 24127479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory morbidity, atopy and asthma at school age in preterm infants aged 32-35 weeks.
    Morata-Alba J; Romero-Rubio MT; Castillo-Corullón S; Escribano-Montaner A
    Eur J Pediatr; 2019 Jul; 178(7):973-982. PubMed ID: 31001655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Attributable Risk of Risk Factors for Recurrent Wheezing in Moderate Preterm Infants During the First Year of Life.
    Blanken MO; Korsten K; Achten NB; Tamminga S; Nibbelke EE; Sanders EA; Smit HA; Groenwold RH; Bont L;
    Paediatr Perinat Epidemiol; 2016 Jul; 30(4):376-85. PubMed ID: 27199198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palivizumab prophylaxis in preterm infants and subsequent wheezing/asthma: 10-year follow-up study.
    Kato M; Mochizuki H; Kama Y; Kusuda S; Okada K; Yoshihara S; Furuya H; Simões EAF;
    Pediatr Pulmonol; 2024 Mar; 59(3):743-749. PubMed ID: 38116923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.
    Simões EA; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick L; Groothuis JR;
    J Allergy Clin Immunol; 2010 Aug; 126(2):256-62. PubMed ID: 20624638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
    J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent wheezing in preterm infants: Prevalence and risk factors.
    Simões MCRDS; Inoue Y; Matsunaga NY; Carvalho MRV; Ribeiro GLT; Morais EO; Ribeiro MAGO; Morcillo AM; Ribeiro JD; Toro AADC
    J Pediatr (Rio J); 2019; 95(6):720-727. PubMed ID: 30031764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.
    Sanchez-Luna M; Burgos-Pol R; Oyagüez I; Figueras-Aloy J; Sánchez-Solís M; Martinón-Torres F; Carbonell-Estrany X
    BMC Infect Dis; 2017 Oct; 17(1):687. PubMed ID: 29041909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy.
    Escobar GJ; Masaquel AS; Li SX; Walsh EM; Kipnis P
    BMC Pediatr; 2013 Jun; 13():97. PubMed ID: 23782528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory disorders and hospitalization rates during the second RSV season in preterm infants who received palivizumab prophylaxis during their first RSV season.
    Fanos V; Scarcella A; Puddu M; Gallini F; Tuminelli F; Bragetti P; Gallina MR; Quartulli L; Benincori N; Citro G; Via LD; Barera G; DI Luzio Paparatti U; Merolla R; Romano GV; Guida G; Silvestri M; Rossi GA
    J Chemother; 2009 Jun; 21(3):302-10. PubMed ID: 19567351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full-term infants.
    Mejias A; Wu B; Tandon N; Chow W; Varma R; Franco E; Ramilo O
    Pediatr Allergy Immunol; 2020 Jan; 31(1):47-56. PubMed ID: 31566811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of recurrent wheezing in late preterm infants.
    Gustafson B; Britt RD; Eisner M; Narayanan D; Grayson MH
    Pediatr Pulmonol; 2024 Jan; 59(1):181-188. PubMed ID: 37921550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day care attendance, respiratory tract illnesses, wheezing, asthma, and total serum IgE level in early childhood.
    Celedón JC; Litonjua AA; Ryan L; Weiss ST; Gold DR
    Arch Pediatr Adolesc Med; 2002 Mar; 156(3):241-5. PubMed ID: 11876667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function in former very low birth weight preterm infants in the first year of life.
    Gonçalves DMM; Wandalsen GF; Scavacini AS; Lanza FC; Goulart AL; Solé D; Dos Santos AMN
    Respir Med; 2018 Mar; 136():83-87. PubMed ID: 29501252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study.
    Kumar R; Yu Y; Story RE; Pongracic JA; Gupta R; Pearson C; Ortiz K; Bauchner HC; Wang X
    J Allergy Clin Immunol; 2008 Apr; 121(4):878-84.e6. PubMed ID: 18313129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence.
    Rubner FJ; Jackson DJ; Evans MD; Gangnon RE; Tisler CJ; Pappas TE; Gern JE; Lemanske RF
    J Allergy Clin Immunol; 2017 Feb; 139(2):501-507. PubMed ID: 27312820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.